p53 functions as a cell cycle control protein in osteosarcomas
- PMID: 2233717
- PMCID: PMC361354
- DOI: 10.1128/mcb.10.11.5772-5781.1990
p53 functions as a cell cycle control protein in osteosarcomas
Abstract
Mutations in the p53 gene have been associated with a wide range of human tumors, including osteosarcomas. Although it has been shown that wild-type p53 can block the ability of E1a and ras to cotransform primary rodent cells, it is poorly understood why inactivation of the p53 gene is important for tumor formation. We show that overexpression of the gene encoding wild-type p53 blocks the growth of osteosarcoma cells. The growth arrest was determined to be due to an inability of the transfected cells to progress into S phase. This suggests that the role of the p53 gene as an antioncogene may be in controlling the cell cycle in a fashion analogous to the check-point control genes in Saccharomyces cerevisiae.
Similar articles
-
Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression.Oncogene. 1993 Jun;8(6):1519-28. Oncogene. 1993. PMID: 8502477
-
Sensitization and caffeine potentiation of cisplatin cytotoxicity resulting from introduction of wild-type p53 gene in human osteosarcoma.Anticancer Res. 2000 Jan-Feb;20(1A):235-42. Anticancer Res. 2000. PMID: 10769661
-
The p53 tumor suppressor gene and gene product.Princess Takamatsu Symp. 1989;20:221-30. Princess Takamatsu Symp. 1989. PMID: 2488233 Review.
-
p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.PLoS One. 2014 Dec 9;9(12):e114757. doi: 10.1371/journal.pone.0114757. eCollection 2014. PLoS One. 2014. PMID: 25490093 Free PMC article.
-
Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest.Mol Cell Biol. 1991 Mar;11(3):1344-52. doi: 10.1128/mcb.11.3.1344-1352.1991. Mol Cell Biol. 1991. PMID: 1996096 Free PMC article.
Cited by
-
Mitotic catastrophe triggered in human cancer cells by the viral protein apoptin.Cell Death Dis. 2013 Feb 7;4(2):e487. doi: 10.1038/cddis.2013.2. Cell Death Dis. 2013. PMID: 23392175 Free PMC article.
-
Cancer risks from germline p53 mutations.J Clin Invest. 1992 Nov;90(5):1637-41. doi: 10.1172/JCI116034. J Clin Invest. 1992. PMID: 1430194 Free PMC article. Review. No abstract available.
-
Repression of the basal c-fos promoter by wild-type p53.Nucleic Acids Res. 1992 Aug 11;20(15):4083-7. doi: 10.1093/nar/20.15.4083. Nucleic Acids Res. 1992. PMID: 1508692 Free PMC article.
-
Differential suppression of human cervical cancer cell growth by adenovirus delivery of p53 in vitro: arrest phase of cell cycle is dependent on cell line.Jpn J Cancer Res. 2002 Sep;93(9):1012-9. doi: 10.1111/j.1349-7006.2002.tb02478.x. Jpn J Cancer Res. 2002. PMID: 12359055 Free PMC article.
-
G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation.Jpn J Cancer Res. 1999 Dec;90(12):1364-72. doi: 10.1111/j.1349-7006.1999.tb00721.x. Jpn J Cancer Res. 1999. PMID: 10665655 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous